CVS Caremark Corporation, the second-largest drugstore chain in the U.S., plans to acquire the Medicare Prescription Drug business of Universal American for about $1.25 billion.
CVS Caremark Corporation, the second-largest drugstore chain in the U.S., plans to acquire the Medicare Prescription Drug business of Universal American for about $1.25 billion.
CVS Caremark will acquire all of the outstanding stock of Universal American and distribute the shares of a newly formed public company to Universal American shareholders. The new company will own all other operations of Universal American, including its Medicare Advantage and Traditional Insurance businesses.
According to the Los Angeles Times, the size of CVS Caremark's business that provides prescription drug coverage under the Medicare Part D program will more than double because of the deal.
Medco Health Solutions, Inc.'s Medicare Part D prescription benefits management agreement with MemberHealth, LLC, a subsidiary of Universal American, has been terminated as a result of the CVS Caremark acquisition announcement. Medco provides pharmacy benefit management services to beneficiaries of various Medicare plans that are under contract with the Centers for Medicare and Medicaid Services.
"Universal American will now focus its energies on overcoming our regulatory challenges and building momentum in the Medicare Advantage business to take advantage of our Healthy Collaboration approach to healthcare," said Richard Barasch, chairman and CEO of Universal American, in a press statement.
The transaction is expected to close by the end of the second quarter of 2011 and is subject to customary closing conditions.
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen